-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Traumatic brain injury (TBI) is a leading cause of death and disability in the United States and globally
However, long-term follow-up studies report that there is a considerable difference in the degree of recovery and residual disability after MSTBI
The "TBI Research and Transformation of Clinical Knowledge" (TRACK-TBI) study is the largest prospective observational study in the United States, comprehensively investigating the natural recovery from the acute phase (for example, hospital admission) to the chronic phase (for example, 12 months after injury) after TBI History
In this way, Michael A.
, To explore the systematic monitoring of functional results in the early stage (ie 2 weeks) after injury and 3, 6, and 12 months after injury
By 12 months after injury, 142 of 271 severe TBI patients (52.
By 12 months after injury, 142 of 271 severe TBI patients (52.
Among the participants who were in a vegetative state at 2 weeks, 62 out of 79 (78%) regained consciousness, and 14 out of 56 (25%) regained their sense of direction 12 months ago
The significance of this study lies in the findings: msTBI patients often show major functional benefits, including regaining independence, from 2 weeks to 12 months after injury
Patients with msTBI often show major functional benefits from 2 weeks to 12 months after injury, including regaining independence
Leave a message here
